Lamotrigine Tablet
Product Images NDC 51672-4255

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 51672-4255). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container Label (100 mg Label)

Container Label (100 mg Label)
This -processed text provides information about a medication called Lamotrigine, specifically orally disintegrating tablets containing 100 mg of the active ingredient. It mentions the caution to verify the product dispensed, advises to dispense the accompanying Medication Guide to each patient, and provides temperature storage instructions. The text also includes details about dosage information, child-resistant packaging, and manufacturer and distributor information for the product.*
FDA Label Image

Container Label (200 mg Label)

Container Label (200 mg Label)
This is information about Lamotrigine Orally Disintegrating Tablets, USP, with a strength of 200 mg. It includes a caution to verify the product dispensed and to provide a Medication Guide to each patient. The usual dosage information is mentioned, and storage instructions indicate to keep the tablets at 20° to 25°C (68° to 77°F) with permitted excursions to 15° to 30°C (59° to 86°F). The manufacturer is Taro Pharmaceutical Industries Ltd. from Haifa Bay, Israel, and the distributor is Sun Pharmaceutical Industries, Inc. from Cranbury, NJ. There are guidelines for dispensing, including storing in a tight container, not using if the printed safety seal is broken or missing, and replacing the packaging material after each use.*
FDA Label Image

Container Label (25 mg Label)

FDA Label Image

Container Label (50 mg Label)

Container Label (50 mg Label)
The text mentions an orally disintegrating tablet containing 50 mg of Lamotrigine, USP. The medication guide is available at a specified website. It provides caution to verify the product dispensed and includes storage instructions. The tablets are manufactured by Taro Pharmaceutical Industries. The package is distributed by Sun Pharmaceutical Industries, Inc. Make sure to dispense the medication guide with the product and store the tablets at room temperature.*
FDA Label Image

Chemical Structure (Lamotrigine 01)

FDA Label Image

Figure 1 (Lamotrigine 02)

FDA Label Image

Figure 2 (Lamotrigine 03)

FDA Label Image

Pg 1 (Pg 1)

Pg 1 (Pg 1)
This is a medication guide for Lamotrigine Orally Disintegrating Tablets, which highlights important information such as the risk of experiencing a serious skin rash that may require hospitalization or even lead to death. It mentions specific symptoms to watch out for, including skin rash, blistering, hives, painful sores, and more, which could indicate a severe skin reaction. Additionally, it discusses potential serious reactions such as blood problems, liver issues, allergic reactions, and organ-related problems that may occur while taking this medication. The text advises patients to notify their healthcare provider immediately if they experience any of the listed symptoms.*
FDA Label Image

Pg 2 (Pg 2)

Pg 2 (Pg 2)
This text is discussing the potential side effects of Lamotrigine orally disintegrating tablets, including suicidal thoughts or actions, changes in mood such as depression and anxiety, and physical symptoms like shortness of breath and chest pain. It also mentions the importance of not stopping the medication suddenly and the possibility of causing aseptic meningitis. Users are advised to contact their healthcare provider if they experience any concerning symptoms and to watch for signs of suicidal thoughts or actions. Regular follow-up visits are recommended for monitoring any changes in mood or behavior.*
FDA Label Image

Pg 3 (Pg 3)

Pg 3 (Pg 3)
Lamotrigine orally disintegrating tablets are prescription medicines used to treat certain types of seizures and bipolar I disorder. It is important to ensure you are receiving the correct medication, as taking the wrong one can cause serious health problems. Always verify the tablets received match the description provided, and contact your healthcare provider or pharmacist if any side effects occur. These orally disintegrating tablets come in different strengths and shapes, and should not be taken if you are allergic to lamotrigine or any inactive ingredients. It is recommended to follow the instructions carefully and consult with a healthcare professional if needed.*
FDA Label Image

Pg 4 (Pg 4)

Pg 4 (Pg 4)
This text provides important information for individuals considering taking lamotrigine orally disintegrating tablets. It covers various health conditions and factors to discuss with a healthcare provider before starting the medication, such as allergies, depression, heart problems, pregnancy, and breastfeeding. It also advises on interactions with other medications, dosage instructions, and what to do in case of a missed dose or overdose. Additionally, it mentions potential side effects and precautions to take while on the medication, such as avoiding certain activities until the effects are known. This detailed guide aims to inform individuals about the usage and potential risks associated with lamotrigine orally disintegrating tablets.*
FDA Label Image

Pg 5 (Pg 5)

Pg 5 (Pg 5)
This text provides information about common side effects of lamotrigine orally disintegrating tablets, how to store the tablets, and general information about their safe and effective use. It includes details about reporting side effects to the FDA, storage instructions, precautions on usage, and the list of ingredients in the tablets. It also mentions that the medication guide is not approved by the U.S. Food and Drug Administration.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.